# SOX9

## Overview
SOX9 is a gene that encodes the SRY-box transcription factor 9, a critical transcription factor involved in various developmental and cellular processes. The SOX9 protein is characterized by its high-mobility group (HMG) box domain, which facilitates DNA binding and bending, allowing it to regulate gene expression by interacting with specific DNA motifs and other proteins (Harley2002The; Geraldo2016Dimerization). As a transcription factor, SOX9 plays a pivotal role in chondrogenesis, the development of pancreatic progenitor cells, and the maintenance of stem and progenitor cell pools in adult tissues (Lynn2007Sox9; Lefebvre1997SOX9). Mutations in the SOX9 gene are linked to several clinical conditions, including campomelic dysplasia and various cancers, highlighting its significance in both normal development and disease states (Wagner1994Autosomal; Jo2014The).

## Structure
The SOX9 protein is characterized by several distinct domains that contribute to its function as a transcription factor. It contains a high-mobility group (HMG) box domain, which is a non-canonical DNA-binding domain that binds to the minor groove of DNA, allowing it to bend DNA and function as a transcriptional regulator (Harley2002The; Geraldo2016Dimerization). The HMG domain also includes two nuclear localization signals (NLSs) that are crucial for its nuclear import, and mutations in these regions can lead to nuclear import defects (Harley2002The).

The protein also features a dimerization (DIM) domain, which is responsible for self-dimerization, influencing its transactivation activity (Geraldo2016Dimerization). The transactivation domains (TADs), including the PQS and PQA domains, are involved in transcriptional activation, with the PQA domain being exclusive to mammals and enhancing the activity of PQS (Harley2002The; Geraldo2016Dimerization).

SOX9 undergoes post-translational modifications, such as phosphorylation through interaction with protein kinase A, which is important for its function (Harley2002The). The protein can also interact with other proteins like calmodulin (CaM) and heat shock protein HSP70, forming complexes that are crucial for its transcriptional activity (Harley2002The). These interactions and modifications highlight the complex regulatory mechanisms governing SOX9's role in cellular processes.

## Function
The SOX9 gene encodes a transcription factor that plays a critical role in various developmental processes and cellular functions in healthy human cells. SOX9 is involved in maintaining undifferentiated cell states by repressing differentiation genes such as CDX2 and MUC2 in the intestinal epithelium, where it is regulated by the Wnt signaling pathway (Blache2004SOX9). It is expressed in the proliferative compartment of the intestinal epithelium, particularly in the lower half of the crypts of Lieberkühn, and is associated with cell proliferation (Blache2004SOX9).

In chondrogenesis, SOX9 is a potent activator of the chondrocyte-specific enhancer of the proα1(ii) collagen gene (Col2a1), essential for cartilage formation. It binds to a specific sequence in the Col2a1 enhancer, facilitating interactions with other proteins and the transcription machinery, which is crucial for chondrocyte differentiation and proliferation (Lefebvre1997SOX9; Akiyama2004Interactions).

SOX9 also plays a significant role in the development and maintenance of pancreatic progenitor cells, where it coordinates a transcriptional network involving other transcription factors to regulate the expression of genes essential for endocrine cell differentiation (Lynn2007Sox9). In adult tissues, SOX9 is important for maintaining stem and progenitor cell pools, contributing to tissue repair and regeneration (Jo2014The).

## Clinical Significance
Mutations and alterations in the SOX9 gene are associated with several clinical conditions. Campomelic dysplasia (CD) is a rare skeletal malformation syndrome caused by haploinsufficiency of SOX9 due to deletions or mutations in or around the gene. This condition is characterized by congenital bowing of limb long bones, a small thoracic cage, hypoplastic scapulae, respiratory deficiencies, and sex reversal in XY individuals (Wagner1994Autosomal; Jo2014The). Inactivating mutations in one allele of SOX9 lead to haploinsufficiency, which is the cause of both campomelic dysplasia and XY sex reversal (Wagner1994Autosomal).

SOX9 is also implicated in congenital vertebral malformations (CVM), where a specific missense variant has been linked to scoliosis without other systemic deformities (Wu2019A). Altered SOX9 expression is associated with various cancers, including prostate and colon cancer, where it can influence tumor growth and metastasis. In prostate cancer, SOX9 interacts with the androgen receptor, promoting tumor growth, while in colon cancer, elevated SOX9 expression correlates with lower survival rates (Pritchett2011Understanding). SOX9 is also involved in fibrosis, where its dysregulation leads to excessive extracellular matrix deposition, contributing to conditions like liver fibrosis and kidney glomerulosclerosis (Jo2014The).

## Interactions
SOX9 is a transcription factor that interacts with various proteins and nucleic acids, playing a crucial role in gene regulation. It binds to DNA at specific motifs, including the canonical consensus motif A/T A/T CAA A/T G, and a novel motif referred to as Motif 1, primarily in promoter regions and 5' UTRs, indicating its role in transcriptional regulation (Shi2015Contextspecific). In chondrocytes, SOX9 binds to enhancer elements of genes like COL2A1 and COL11A2, often in promoter regions and first introns, which are associated with chondrocyte-specific enhancers (Oh2010Identification).

SOX9 also forms homodimers through direct interaction with DNA, which stabilizes the protein and enhances its binding affinity (Saravanan2024Characterization). In colorectal cancer cells, SOX9 is recruited by the NF-Y transcription factor to CCAAT promoters, where it acts as a cofactor rather than directly binding to DNA. This interaction is essential for the transactivation of cell cycle regulatory genes such as CCNB1 and CDK1 (Shi2015Contextspecific).

The protein's interaction with nucleic acids is crucial for its stability and function, with cooperative binding observed in various contexts. These interactions highlight SOX9's versatile role in regulating gene expression across different cell types and conditions (Saravanan2024Characterization).


## References


[1. (Harley2002The) Vincent R. Harley. The molecular action of testis‐determining factors sry and sox9. March 2002. URL: http://dx.doi.org/10.1002/0470868732.ch6, doi:10.1002/0470868732.ch6. This article has 11 citations.](https://doi.org/10.1002/0470868732.ch6)

[2. (Lynn2007Sox9) F. C. Lynn, S. B. Smith, M. E. Wilson, K. Y. Yang, N. Nekrep, and M. S. German. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proceedings of the National Academy of Sciences, 104(25):10500–10505, June 2007. URL: http://dx.doi.org/10.1073/pnas.0704054104, doi:10.1073/pnas.0704054104. This article has 199 citations.](https://doi.org/10.1073/pnas.0704054104)

[3. (Lefebvre1997SOX9) Véronique Lefebvre, Wendong Huang, Vincent R. Harley, Peter N. Goodfellow, and Benoit de Crombrugghe. Sox9 is a potent activator of the chondrocyte-specific enhancer of the proα1(ii) collagen gene. Molecular and Cellular Biology, 17(4):2336–2346, April 1997. URL: http://dx.doi.org/10.1128/mcb.17.4.2336, doi:10.1128/mcb.17.4.2336. This article has 880 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.17.4.2336)

[4. (Oh2010Identification) Chun-do Oh, Sankar N. Maity, Jing-Fang Lu, Jiexin Zhang, Shoudan Liang, Francoise Coustry, Benoit de Crombrugghe, and Hideyo Yasuda. Identification of sox9 interaction sites in the genome of chondrocytes. PLoS ONE, 5(4):e10113, April 2010. URL: http://dx.doi.org/10.1371/journal.pone.0010113, doi:10.1371/journal.pone.0010113. This article has 80 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0010113)

[5. (Shi2015Contextspecific) Zhongcheng Shi, Chi-I Chiang, Paul Labhart, Yanling Zhao, Jianhua Yang, Toni-Ann Mistretta, Susan J. Henning, Sankar N. Maity, and Yuko Mori-Akiyama. Context-specific role of sox9 in nf-y mediated gene regulation in colorectal cancer cells. Nucleic Acids Research, 43(13):6257–6269, June 2015. URL: http://dx.doi.org/10.1093/nar/gkv568, doi:10.1093/nar/gkv568. This article has 52 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkv568)

6. (Saravanan2024Characterization) Characterization of DNA binding and oligomerization domains of stem cell transcription factor Sox9 and Sox5. This article has 0 citations.

[7. (Blache2004SOX9) Philippe Blache, Marc van de Wetering, Isabelle Duluc, Claire Domon, Philippe Berta, Jean-Noël Freund, Hans Clevers, and Philippe Jay. Sox9 is an intestine crypt transcription factor, is regulated by the wnt pathway, and represses the cdx2 and muc2 genes. The Journal of Cell Biology, 166(1):37–47, July 2004. URL: http://dx.doi.org/10.1083/jcb.200311021, doi:10.1083/jcb.200311021. This article has 596 citations.](https://doi.org/10.1083/jcb.200311021)

[8. (Jo2014The) Alice Jo, Sahitya Denduluri, Bosi Zhang, Zhongliang Wang, Liangjun Yin, Zhengjian Yan, Richard Kang, Lewis L. Shi, James Mok, Michael J. Lee, and Rex C. Haydon. The versatile functions of sox9 in development, stem cells, and human diseases. Genes &amp; Diseases, 1(2):149–161, December 2014. URL: http://dx.doi.org/10.1016/j.gendis.2014.09.004, doi:10.1016/j.gendis.2014.09.004. This article has 366 citations.](https://doi.org/10.1016/j.gendis.2014.09.004)

[9. (Akiyama2004Interactions) Haruhiko Akiyama, Jon P. Lyons, Yuko Mori-Akiyama, Xiaohong Yang, Ren Zhang, Zhaoping Zhang, Jian Min Deng, Makoto M. Taketo, Takashi Nakamura, Richard R. Behringer, Pierre D. McCrea, and Benoit de Crombrugghe. Interactions between sox9 and β-catenin control chondrocyte differentiation. Genes &amp; Development, 18(9):1072–1087, May 2004. URL: http://dx.doi.org/10.1101/gad.1171104, doi:10.1101/gad.1171104. This article has 617 citations.](https://doi.org/10.1101/gad.1171104)

[10. (Pritchett2011Understanding) James Pritchett, Varinder Athwal, Neil Roberts, Neil A Hanley, and Karen Piper Hanley. Understanding the role of sox9 in acquired diseases: lessons from development. Trends in Molecular Medicine, 17(3):166–174, March 2011. URL: http://dx.doi.org/10.1016/j.molmed.2010.12.001, doi:10.1016/j.molmed.2010.12.001. This article has 106 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.molmed.2010.12.001)

[11. (Wagner1994Autosomal) Thomas Wagner, Jutta Wirth, Jobst Meyer, Bernhard Zabel, Marika Held, Jürgen Zimmer, Juan Pasantes, Franca Dagna Bricarelli, Jürgen Keutel, Elisabeth Hustert, Ulrich Wolf, Niels Tommerup, Werner Schempp, and Gerd Scherer. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the sry-related gene sox9. Cell, 79(6):1111–1120, December 1994. URL: http://dx.doi.org/10.1016/0092-8674(94)90041-8, doi:10.1016/0092-8674(94)90041-8. This article has 1197 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/0092-8674(94)90041-8)

[12. (Wu2019A) Nan Wu, Lianlei Wang, Jianhua Hu, Sen Zhao, Bowen Liu, Yaqi Li, Huakang Du, Yuanqiang Zhang, Xiaoxin Li, Zihui Yan, Shengru Wang, Yipeng Wang, Jianguo Zhang, Zhihong Wu, and Guixing Qiu. A recurrent rare sox9 variant (m469v) is associated with congenital vertebral malformations. Current Gene Therapy, 19(4):242–247, November 2019. URL: http://dx.doi.org/10.2174/1566523219666190924120307, doi:10.2174/1566523219666190924120307. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.2174/1566523219666190924120307)

[13. (Geraldo2016Dimerization) Marcos Tadeu Geraldo, Guilherme Targino Valente, Rafael Takahiro Nakajima, and Cesar Martins. Dimerization and transactivation domains as candidates for functional modulation and diversity of sox9. PLOS ONE, 11(5):e0156199, May 2016. URL: http://dx.doi.org/10.1371/journal.pone.0156199, doi:10.1371/journal.pone.0156199. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0156199)